Galapagos NV
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
23 aug 2024 - 07:10
Statutory name
Galapagos NV
Title
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma
Date last update: 23 August 2024